Introducing the FDA Drug Approval Calendar

See which approvals could impact your portfolio this week. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe Hi there, We just launched new tools we think you’ll love, especially if you keep an eye on biotech, pharma, or healthcare stocks. These stocks often react sharply to FDA news, and now you can track those key events before the headlines hit. Introducing the FDA Drug Approval Calendar Stay one step ahead with a clean, easy-to-navigate calendar that tracks: Prescription Drug User Fee Act dates New Drug and Biologics License Applications Complete Response Letters Trial results, safety updates, and more Filter by company, drug, event type, or date to surface the data that matters most to your watchlist. Now on Company Profiles: FDA Activity at a Glance Companies with FDA activity in the past year now have a dedicated tab showing: Color-coded drug timelines Key milestones and decision points Straightforward summaries It’s a fast, visual way to understand a company’s pipeline and the potential market impact of what’s next. These tools are now live and available to all MarketBeat users. Click here to start exploring. Have feedback or questions? We’d love to hear them. Just hit reply to this email. Matthew Paulson MarketBeat P.S. You might be surprised how many companies on your watchlist have FDA events in the pipeline. Take a look and see what’s coming. Thank you for subscribing to MarketBeat!   MarketBeat empowers investors to make better trading decisions by offering up-to-the-minute financial information and unbiased investment analysis.   If you have questions about your subscription, don't hesitate to contact our U.S. based support team at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   Copyright 2006-2025 MarketBeat Media, LLC. 345 N Reid Pl., Suite 620, Sioux Falls, South Dakota 57103-7078. United States of America..   See Also: New Federal Land Rush About to Start? (From Stansberry Research)